CD8A and neoplasm: Increased prevalence of CD8+ T cells is generally associated with favorable outcomes in immunotherapy [30], but the B16F10 tumor model is known to be “immunologically cold” and contain weak natural antigens that may limit the effectiveness of antigen-specific responses [31,32].